Enzo Biochem Inc (NYSE:ENZ)
$ 1.13 -0.04 (-3.42%) Market Cap: 57.88 Mil Enterprise Value: 4.83 Mil PE Ratio: 1.69 PB Ratio: 0.81 GF Score: 38/100

Q1 2022 Enzo Biochem Inc Earnings Call Transcript

Dec 15, 2021 / 09:30PM GMT
Release Date Price: $3.48 (+0.29%)
Operator

Greetings. Welcome to the Enzo Biochem First Quarter 2022 Financial Results and Business Update Conference Call. (Operator Instructions) Please note, this conference is being recorded.

I will now turn the conference over to your host, David Holmes of LifeSci Advisors and Investor Relations for Enzo Biochem. You may begin.

David Holmes;Director;LifeSci Advisors
Investor Relations

Thank you very much, operator, and good afternoon, everyone. Joining us today from the company are Hamid Erfanian, Chief Executive Officer; and David Bench, Chief Financial Officer. Enzo issued a press release detailing its financial results for the first quarter this afternoon and is now available on the Investor Relations section of the Enzo website.

Before we begin, I would like to read the company's safe harbor statement. Except for historical information, the matters discussed in this news release may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot